1. Academic Validation
  2. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda

Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda

  • Hum Mol Genet. 2003 Nov 15;12(22):3017-24. doi: 10.1093/hmg/ddg320.
Fabrice Chimienti 1 Ronald C Hogg Laure Plantard Caroline Lehmann Noureddine Brakch Judith Fischer Marcel Huber Daniel Bertrand Daniel Hohl
Affiliations

Affiliation

  • 1 Laboratory for Cutaneous Biology, Dermatology Unit, Beaumont Hospital, CHUV, Lausanne, Switzerland.
Abstract

Mal de Meleda is an autosomal recessive inflammatory and keratotic palmoplantar skin disorder due to mutations in the ARS B gene, encoding for SLURP-1 (secreted mammalian Ly-6/uPAR-related protein 1). SLURP-1 belongs to the Ly-6/uPAR superfamily of receptor and secreted proteins, which participate in signal transduction, immune cell activation or cellular adhesion. The high degree of structural similarity between SLURP-1 and the three fingers motif of snake neurotoxins and Lynx1 suggests that this protein interacts with the neuronal acetylcholine receptors. We found that SLURP-1 potentiates the human alpha 7 nicotinic acetylcholine receptors that are present in keratinocytes. These results identify SLURP-1 as a secreted epidermal neuromodulator which is likely to be essential for both epidermal homeostasis and inhibition of TNF-alpha release by macrophages during wound healing. This explains both the hyperproliferative as well as the inflammatory clinical phenotype of Mal de Meleda.

Figures